Metallic and metal oxide nanoparticles |
Metallic NPs are solid inorganic particles (among 1–100 nm) that are commonly used in HNC treatments based on their physicochemical properties:
-
-
Biocompatibility
-
-
Photostability
-
-
Photothermal conversion
-
-
Optical features
-
-
Radiosensitizer activity
-
-
Surface functionalization versatility
-
-
Enhanced permeability and retention effect
-
-
Plasmon resonance properties (Au)
-
-
Photocytotoxic effects (Gd)
-
-
Magnetic properties (Fe3O4)
-
-
Cellular cytotoxicity induction (Ag)
-
-
Redox-modulatory effect (CeO2)
-
-
Easily recognized by innate immune system
-
-
Long-term health risk still unknown
|
[46,50,51,54,59,66,68,69,74,77,84] |
Liposomes |
Liposomes are artificial nanometric (around 20–150 nm) vesicles formed by a phospholipid bilayer with an aqueous inner space. They are widely investigated as a nanocarrier for anticancer agents, based on their properties:
-
-
Biodegradability
-
-
Biocompatibility of the phospholipid bilayer
-
-
Entrapment of hydrophilic and hydrophobic molecules (individually or simultaneously in the aqueous cavity)
-
-
Affinity to mammalian cell membranes
-
-
Enhanced cellular uptake and biodistribution
-
-
High drug payload
-
-
Simple synthesis methods
-
-
Low batch-to-batch variability
-
-
Easy surface conjugation
-
-
Formulation flexibility
|
[89,90,91,95,96,97] |
Nanomicelles and microemulsions |
Nanomicelles are colloidal nanoparticles (about 5–100 nm) synthesized from amphiphilic monomers that self-aggregate. They consist of two main regions: an inner hydrophobic core and an outer hydrophilic shell. Nanomicelles exhibit interesting drug delivery features based on their characteristics:
-
-
Encapsulation of nonpolar molecules (hydrophobic core)
-
-
Easy surface conjugation with polar drugs or ligands
-
-
Enhanced solubility of hydrophobic molecules
-
-
Drug targeting and specificity
-
-
High drug load capacity
-
-
Great colloidal stability
-
-
Stimuli-responsive (pH, temperature, light, ultrasound)
-
-
Longer circulation time (avoid the reticuloendothelial system)
-
-
Co-delivery of hydrophobic and hydrophilic anticancer agents
-
-
Premature drug release
-
-
Poor control of sustained release
-
-
Inability to encapsulate hydrophilic agents
|
[105,106,108,114] |
Polymeric nanoparticles |
Polymeric nanoparticles are colloidal particles (among 100–300 nm) prepared with biocompatible polymers for drug delivery. They offer several advantages during drug delivery, based on their properties:
-
-
Biodegradability
-
-
Biocompatibility
-
-
Natural or synthetic polymers
-
-
Predictable pharmacokinetics (synthetic polymers)
-
-
High encapsulation efficiency
-
-
Controlled drug release
-
-
Cationic, anionic, or nonionic properties (depending on the polymer)
-
-
Mucoadhesive features (chitosan)
-
-
pH sensitivity (chitosan)
-
-
Initial boost prevention
-
-
High purity and reproducibility (synthetic polymers)
-
-
Nonimmunogenic properties (natural polymers)
-
-
Coating features
-
-
Enhanced solubility
-
-
Easy preparation technique
-
-
Good control over size and size distribution
-
-
Prolonged blood circulation (synthetic polymers)
-
-
Approved by FDA and EMA (PLGA)
-
-
Reduced reticuloendothelial system captures
-
-
Poor stability and easy degradation (natural polymers)
-
-
Possible accumulation in the liver or the spleen
|
[54,106,117,118,119,120,127,128,133,134,139,145] |
Mesoporous |
Mesoporous silica nanoparticles represent a promising inorganic nanocarrier (among 50–200 nm) with very interesting properties, such as:
-
-
Biocompatibility
-
-
Biodegradability
-
-
Tunable pore size
-
-
Easy surface functionalization
-
-
Large mesopore volume
-
-
Uniform mesoporosity
-
-
Flexible structure
-
-
High payload capability
-
-
Great encapsulation efficiency
-
-
Sustained drug release
-
-
Minimum toxicity
-
-
Electrostatic adsorption of hydrophilic molecules
-
-
FDA approval
|
[166,167,168,169] |
Solid lipid nanoparticles |
Solid lipid nanoparticles are colloidal nanovehicles (around 50–1000 nm) synthesized with lipids that remain solid at room temperature and surfactants. Among their main characteristics are:
-
-
Biocompatibility
-
-
Biodegradability
-
-
High drug stability
-
-
Improved intracellular uptake
-
-
Prevention of drug leaking during administration and prevention of an early burst delivery
-
-
Feasibility of incorporating hydrophilic and lipophilic molecules
-
-
Improved bioavailability of poorly water-soluble agents
-
-
Possible drug expulsion during storage
-
-
Poor drug loading capacity
|
[171,172,173,175,176,177,178] |